6533b831fe1ef96bd1298cda
RESEARCH PRODUCT
Use of primary and secondary pegfilgrastim prophylaxis for reducing incidence of neutropenia: Findings from a large study in German clinical practice (PROTECT)
Martina SchmidtB. OtrembaH. EschenburgM. GeberthC.m. KurbacherP. Ramdohrsubject
medicine.medical_specialtybusiness.industryIncidence (epidemiology)HematologyNeutropeniamedicine.diseaselanguage.human_languageClinical PracticeGermanOncologyLarge studymedicinelanguageIntensive care medicinebusinessPegfilgrastimmedicine.drugyear | journal | country | edition | language |
---|---|---|---|---|
2018-10-01 | Annals of Oncology |